Live from the NIH registry
Studies recruiting near Murfreesboro right now
Top 25 of 79 recruiting studies, sorted by proximity — each links to its official registry page
Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
Alzheimer Disease, Dementia
N/A
Interventional 456 participants sought
National HealthCare Corporation — Murfreesboro, Tennessee (1.2 mi)
· Sponsor: University of Alabama, Tuscaloosa
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Relapsing Multiple Sclerosis, Multiple Sclerosis
N/A
Observational 2,000 participants sought
TG Therapeutics Investigational Trial Site — Mount Juliet, Tennessee (25.0 mi)
· Sponsor: TG Therapeutics, Inc.
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
Moderate to Severe Chronic Obstructive Pulmonary Disease
Phase 2, Phase 3
Interventional 1,156 participants sought
Clinical Trials Center of Middle Tennessee, LLC — Franklin, Tennessee (26.1 mi)
· Sponsor: Pfizer
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
NASH With Fibrosis, MASH With Fibrosis
Phase 3
Interventional 1,650 participants sought
Akero Clinical Study Site — Hermitage, Tennessee (26.7 mi)
· Sponsor: Akero Therapeutics, Inc
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
Major Depressive Disorder
Phase 2
Interventional 164 participants sought
Psychiatric Consultants, PC — Franklin, Tennessee (26.1 mi)
· Sponsor: Syndeio Biosciences, Inc
Exactech Shoulder Post Market Clinical Follow-up Study
Osteo Arthritis Shoulders, Osteonecrosis
N/A
Observational 20,000 participants sought
Bone and Joint Institute of Tenessee — Franklin, Tennessee (26.1 mi)
· Sponsor: Exactech
Study of ACR-2316 in Specific Advanced Solid Tumors
Specific Advanced Solid Tumors
Phase 1, Phase 2
Interventional 100 participants sought
Tennessee Oncology — Franklin, Tennessee (26.1 mi)
· Sponsor: Acrivon Therapeutics
A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris
Lichen Planopilaris
Phase 2, Phase 3
Interventional 342 participants sought
Clinical Trial Site — Murfreesboro, Tennessee (1.2 mi)
· Sponsor: Priovant Therapeutics, Inc.
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Progressive Pulmonary Fibrosis, Interstitial Lung Disease
Phase 3
Interventional 698 participants sought
Clinical Trials Center of Middle Tennessee, LLC — Franklin, Tennessee (26.1 mi)
· Sponsor: United Therapeutics
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Psoriasis, Overweight or Obesity
Phase 4
Interventional 200 participants sought
DelRicht Research - Thompson's Station — Smyrna, Tennessee (11.0 mi)
· Sponsor: Eli Lilly and Company
Study of DONQ52 in Active Celiac Disease
Celiac Disease
Phase 2
Interventional 92 participants sought
Digestive Health Research, LC — Hermitage, Tennessee (26.7 mi)
· Sponsor: Chugai Pharmaceutical
Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
Refractory Differentiated Thyroid Gland Carcinoma
Phase 3
Interventional 264 participants sought
Vanderbilt-Ingram Cancer Center Cool Springs — Franklin, Tennessee (26.1 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma
Phase 3
Interventional 880 participants sought
Vanderbilt-Ingram Cancer Center at Franklin — Franklin, Tennessee (26.1 mi)
· Sponsor: NRG Oncology
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
Obesity or Overweight, Weight-Related Comorbidity
Phase 3
Interventional 500 participants sought
Research Site — Franklin, Tennessee (26.1 mi)
· Sponsor: AstraZeneca
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
Intracranial Meningioma, Recurrent Meningioma
Phase 2
Interventional 124 participants sought
Vanderbilt-Ingram Cancer Center Cool Springs — Franklin, Tennessee (26.1 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Endometrial Cancer Vaginal Fluid Specimen Collection Study
Abnormal Uterine Bleeding (AUB), Endometrial Cancer
N/A
Observational 4,200 participants sought
Murfreesboro Medical Clinic — Murfreesboro, Tennessee (1.2 mi)
· Sponsor: Exact Sciences Corporation
A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis
Non-cystic Fibrosis Bronchiectasis
Phase 2
Interventional 284 participants sought
Clinical Trials Center of Middle Tennessee — Franklin, Tennessee (26.1 mi)
· Sponsor: Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA
Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular Carcinoma
Hepatocellular Carcinoma (HCC)
Phase 1
Interventional 246 participants sought
HCA Research Institute, LLC — Brentwood, Tennessee (24.3 mi)
· Sponsor: Shanghai Henlius Biotech
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Multiple conditions
Phase 2
Interventional 314 participants sought
Vanderbilt-Ingram Cancer Center Cool Springs — Franklin, Tennessee (26.1 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Assess the Effectiveness and Safety of GSK3862995B in Adults With Bronchiectasis
Bronchiectasis
Phase 2
Interventional 363 participants sought
GSK Investigational Site — Franklin, Tennessee (26.1 mi)
· Sponsor: GlaxoSmithKline
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 626 participants sought
Local Institution - 007-928-F — Murfreesboro, Tennessee (1.2 mi)
· Sponsor: Mirati Therapeutics Inc.
A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
Atopic Dermatitis
Phase 3
Interventional 675 participants sought
International Clinical Research - Tennessee /ID# 268548 — Murfreesboro, Tennessee (1.2 mi)
· Sponsor: AbbVie
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
Weight Management
Phase 3
Interventional 4,500 participants sought
Research Site — Franklin, Tennessee (26.1 mi)
· Sponsor: AstraZeneca
Registry Study for Radiation Therapy Outcomes
Neoplasms
N/A
Observational 50,000 participants sought
Tennessee Oncology Proton Center — Franklin, Tennessee (26.1 mi)
· Sponsor: Proton Collaborative Group
Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity
Obesity and Overweight
Phase 3
Interventional 3,501 participants sought
Civia Health Nashville — La Vergne, Tennessee (14.9 mi)
· Sponsor: Pfizer